A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HDAC / histone deacetylase inhibitor

[Related PubMed/MEDLINE]
Total Number of Papers: 18
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HDAC  (>> Co-occurring Abbreviation)
Long Form:   histone deacetylase inhibitor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer. CRC, HCQ
2021 A new paradigm for a new simple chemical: butyrate & immune regulation. NF-kappaB, SCFAs, SLC5A8
2021 EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck Cancers. Bcl, EGFR, HNSCC
2021 Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer. TNBC
2021 Repression of HDAC5 by acetate restores hypothalamic-pituitary-ovarian function in type 2 diabetes mellitus. ACA, HPO, T2DM
2021 Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT). alpha-SMA, E-cad, EMT, HSCs, N-cad, SAHA, TGF-beta, VIM
2020 Efficacy of Panobinostat for the Treatment of Multiple Myeloma. ---
2019 Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm. CNS, VEP, VPA
2018 Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells. 5-aza, CAR, CEA, E/T
10  2017 Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity. ---
11  2017 High-Resolution Parallel Reaction Monitoring with Electron Transfer Dissociation for Middle-Down Proteomics: An Application to Study the Quantitative Changes Induced by Histone Modifying Enzyme Inhibitors and Activators. ETD, PRM
12  2015 Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells. hESCs, SAHA, TSA, VPA
13  2014 A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study. MTD, TET
14  2013 The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells. ESC
15  2012 Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells. PCas, SAHA, TSA
16  2011 Radioprotection by the histone deacetylase inhibitor phenylbutyrate. PB
17  2009 Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomib. Hsp90, MM
18  2008 The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fear. VPA